Clinical Outcomes in Patients With the Concomitant Use of Clopidogrel and Proton Pump Inhibitors After Percutaneous Coronary Intervention | Zendy

Kishore J. Harjai | Zendy; Chetan Shenoy | Zendy; Pam Orshaw | Zendy; Samer Usmani | Zendy; Judy Boura | Zendy; Rajendra H. Mehta | Zendy

Open Access

Clinical Outcomes in Patients With the Concomitant Use of Clopidogrel and Proton Pump Inhibitors After Percutaneous Coronary Intervention

Author(s) -

Kishore J. Harjai,

Chetan Shenoy,

Pam Orshaw,

Samer Usmani,

Judy Boura,

Rajendra H. Mehta

Publication year - 2011

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.110.958884

Subject(s) - medicine , mace , percutaneous coronary intervention , clopidogrel , myocardial infarction , conventional pci , cardiology , coronary artery disease , concomitant , revascularization , thienopyridine , propensity score matching , angioplasty

The concomitant use of proton pump inhibitors (PPIs) with clopidogrel is suspected to be associated with an adverse impact on clinical outcomes in patients with coronary artery disease. We sought to evaluate whether the use of PPIs with clopidogrel was associated with worse clinical outcomes after percutaneous coronary intervention (PCI) compared with the use of clopidogrel alone.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research